Policy & Regulation
Asymchem adds new member to Board of Scientific Advisors
14 March 2019 -

Asymchem, a CDMO of Intermediates and API's for the pharmaceutical industry, announced yesterday that it has added Dr Scott A May to the Asymchem Board of Scientific Advisors.

Dr May joins Professors Barry Sharpless, Phil Baran, Stephen Buchwald and others currently on the advisory board.

Dr May received his P.D in Chemistry from Indiana University at Bloomington in 1998. In that same year, Dr May joined the Process Research group at Eli Lilly as a senior organic chemist in 1998, and is currently a research fellow in the Small Molecule Design and Development group.